EHDH announces today its intention to finalize in the first half of 2020 the acquisition of Movianto from Owens & Minor (NYSE: OMI).
This transaction would create the European leader in transport and logistics services dedicated to the pharmaceutical sector. Stéphane Baudry, Chairman and CEO of EHDH, will remain the group’s majority shareholder.
The proposed transaction fits with the strategy and vision of both groups. Thanks to this structuring acquisition, EHDH would be able to leverage Movianto’s geographical coverage, reputation and resources to offer the first “one-stop-shop” logistics solution throughout Europe. Selling Movianto would also allows Owens & Minor to focus on its core value proposition. Stéphane Baudry, CEO of EHDH comments on this operation: “The quality of operations, the solid reputation and the values of Movianto are perfectly consistent with EHDH. This opportunity comes at a key moment in our development and in response to market demand for a single contact to handle all logistics and transport services at European level.» The contemplated transaction is subject to ordinary closing conditions, regulatory approvals and mandatory works council discussions. Once this process has been completed, the transaction is expected to be completed in the first half of 2020.
About EHDH
EHDH is a global service provider in the field of logistics and transport in the pharmaceutical sector and B2B express delivery. With integrated proprietary technology, strategic infrastructure and solid expertise in the healthcare sector, EHDH operates all the businesses essential to a reliable, agile and efficient supply chain in the pharmaceutical sector. Supported by organic growth and successful acquisitions, the group offers turnkey support to all healthcare players, encompassing logistics, transport, value-added services and IT services. EHDH is an independent privately owned company founded in 1951 by Marcel Baudry and managed today by his grandson, Stéphane Baudry. EHDH employs 2,600 people spread over more than 300,000 m² in 160 locations in France and Benelux. The group has a cumulative turnover of 650 million euros and aims to accelerate its development in France and abroad. The group is structured around 3 strong complementary brands: CSP, for logistics solutions; Eurotranspharma, for transport solutions dedicated to health products; Ciblex, for express transport solutions dedicated to B2BAbout Movianto O&M Movianto’s international clients benefit from a pan-European network, a broad range of healthcare logistics services, the know-how of the local markets and uncompromising quality standards like ISO 9001 and ISO 13485. The company has expanded rapidly over the last few years. More than 2,500 teammates are managing over 275,000 pallet locations spread over a network of 20 wholly owned warehouses in 11 European countries.
For more information, please contact us:
François Pourcher
Email: francois@teyras.com
Phone +33 610 026 709
About Eurotranspharma
Eurotranspharma is the leading European multi-country carrier 100% dedicated to healthcare products. In conformity with the GDP standards, Eurotranspharma delivers healthcare products in a temperature-controlled environment ( 2-8 °C / 15-25 °C ). Owing to its IT connected tools, Eurotranspharma provides top-quality last mile distribution with the full end-to-end traceability that healthcare products require. The company operates in France, Belgium, the Netherlands, Luxemburg, the Czech Republic and Slovakia with a fleet of 800 vehicles and 1000 specially trained & committed staff.
For more information, please contact:
Laure Murat | Marketing and Communication
Walden Group
laure.murat@walden-group.com
